Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Protein kinase A phosphorylation of tau-serine 214 reorganizes microtubules and disrupts the endothelial cell barrier.

Zhu B, Zhang L, Creighton J, Alexeyev M, Strada SJ, Stevens T.

Am J Physiol Lung Cell Mol Physiol. 2010 Oct;299(4):L493-501. doi: 10.1152/ajplung.00431.2009. Epub 2010 Jul 16.

2.

Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype.

Zhu B, Zhang L, Alexeyev M, Alvarez DF, Strada SJ, Stevens T.

Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L220-8. doi: 10.1152/ajplung.90474.2008. Epub 2008 Nov 21.

3.
4.

Chemoprevention of bicyclol against hepatic preneoplastic lesions.

Zhu B, Liu GT, Wu RS, Strada SJ.

Cancer Biol Ther. 2006 Dec;5(12):1665-73. Epub 2006 Dec 7.

PMID:
17106253
5.

Chemosensitizing multiple drug resistance of human carcinoma by Bicyclol involves attenuated p-glycoprotein, GST-P and Bcl-2.

Zhu B, Liu GT, Zhao YM, Wu RS, Strada SJ.

Cancer Biol Ther. 2006 May;5(5):536-43. Epub 2006 May 5.

PMID:
16627975
7.

Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.

Zhu B, Vemavarapu L, Thompson WJ, Strada SJ.

J Cell Biochem. 2005 Feb 1;94(2):336-50.

PMID:
15526282
8.

Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.

Zhu B, Kelly J, Vemavarapu L, Thompson WJ, Strada SJ.

Biochem Pharmacol. 2004 Aug 1;68(3):479-91.

PMID:
15242814
9.

Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).

Thompson WJ, Ashikaga T, Kelly JJ, Liu L, Zhu B, Vemavarapu L, Strada SJ.

Biochem Pharmacol. 2002 Feb 15;63(4):797-807.

PMID:
11992650
10.

Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells.

Ashikaga T, Strada SJ, Thompson WJ.

Biochem Pharmacol. 1997 Nov 15;54(10):1071-9.

PMID:
9464449
11.

Inhibition of serine-threonine protein phosphatases decreases barrier function of rat pulmonary microvascular endothelial cells.

Diwan AH, Honkanen RE, Schaeffer RC Jr, Strada SJ, Thompson WJ.

J Cell Physiol. 1997 Jun;171(3):259-70.

PMID:
9180895
12.
13.

Comparison of indolidan analog binding sites of drug antibody and sarcoplasmic reticulum with inhibition of cyclic AMP phosphodiesterase.

Ashikaga T, Robertson DW, Sportsman RJ, Strada SJ, Thompson WJ.

J Recept Signal Transduct Res. 1996 Sep-Nov;16(5-6):315-37.

PMID:
8968964
14.

Cyclic nucleotide phosphodiesterases and vascular smooth muscle.

Polson JB, Strada SJ.

Annu Rev Pharmacol Toxicol. 1996;36:403-27. Review.

PMID:
8725396
15.

Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.

Thompson ME, Valentine DL, Strada SJ, Wagner JA, Scammell JG.

Mol Pharmacol. 1994 Nov;46(5):880-9.

PMID:
7969075
16.

Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor.

Barnard JW, Seibert AF, Prasad VR, Smart DA, Strada SJ, Taylor AE, Thompson WJ.

J Appl Physiol (1985). 1994 Aug;77(2):774-81.

17.

Cyclic GMP-dependent protein kinase activity in rat pulmonary microvascular endothelial cells.

Diwan AH, Thompson WJ, Lee AK, Strada SJ.

Biochem Biophys Res Commun. 1994 Jul 29;202(2):728-35.

PMID:
8048944
18.

Effects of poloxamer 188 in a rabbit model of hemorrhagic shock.

Mayer DC, Strada SJ, Hoff C, Hunter RL, Artman M.

Ann Clin Lab Sci. 1994 Jul-Aug;24(4):302-11.

PMID:
7944268
21.

Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation.

Haynes J Jr, Robinson J, Saunders L, Taylor AE, Strada SJ.

Am J Physiol. 1992 Feb;262(2 Pt 2):H511-6.

PMID:
1311530
22.

Effects of hemorrhagic shock and retransfusion on catalase and superoxide dismutase activities in rabbits.

Mayer DC, Strada SJ, Hanson A, Artman M.

Circ Shock. 1992 Feb;36(2):147-53.

PMID:
1582006
23.

Regulatory mechanisms of particulate cyclic nucleotide phosphodiesterases.

Thompson WJ, Lavis VR, Whalin ME, Strada SJ.

Adv Second Messenger Phosphoprotein Res. 1992;25:165-84. Review. No abstract available.

PMID:
1313258
25.

Selective inhibition of cGMP-inhibitable cAMP phosphodiesterase decreases pulmonary vasoreactivity.

Haynes J Jr, Kithas PA, Taylor AE, Strada SJ.

Am J Physiol. 1991 Aug;261(2 Pt 2):H487-92.

PMID:
1652213
26.

Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.

Whalin ME, Scammell JG, Strada SJ, Thompson WJ.

Mol Pharmacol. 1991 Jun;39(6):711-7.

PMID:
1646946
27.

Fura 2 analysis of cytosolic calcium regulation in elutriated rat gastric parietal cells.

Black EW, Cornwell TL, Lincoln TM, Strada SJ, Thompson WJ.

J Cell Physiol. 1989 Jun;139(3):632-40.

PMID:
2472414
28.
30.

Molecular properties of cyclic nucleotide phosphodiesterase isozymes.

Strada SJ, Kithas PA, Whalin ME, Thompson WJ.

Adv Exp Med Biol. 1989;255:409-23.

PMID:
2559603
31.

Inotropic responses to cyclic nucleotide phosphodiesterase inhibitors in immature and adult rabbit myocardium.

Artman M, Kithas PA, Wike JS, Crump DB, Strada SJ.

J Cardiovasc Pharmacol. 1989 Jan;13(1):146-54.

PMID:
2468926
32.

Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.

Black EW, Strada SJ, Garrett RL Jr, Kvietys PR, Thompson WJ, Norman JA.

J Pharmacol Exp Ther. 1989 Jan;248(1):208-14.

PMID:
2464057
33.
34.

Inotropic responses change during postnatal maturation in rabbit.

Artman M, Kithas PA, Wike JS, Strada SJ.

Am J Physiol. 1988 Aug;255(2 Pt 2):H335-42.

PMID:
3407792
35.

Relationships of secretagogue-induced cAMP accumulation and acid secretion in elutriated rat gastric parietal cells.

Black EW, Strada SJ, Thompson WJ.

J Pharmacol Methods. 1988 Aug;20(1):57-78.

PMID:
2457772
37.

Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.

Whalin ME, Garrett RL Jr, Thompson WJ, Strada SJ.

Second Messengers Phosphoproteins. 1988-1989;12(5-6):311-25.

PMID:
2856115
38.

Preparation of dog kidney high-affinity cAMP phosphodiesterase.

Thompson WJ, Shen CC, Strada SJ.

Methods Enzymol. 1988;159:760-6. No abstract available.

PMID:
2842639
39.

Increase in liver protein phosphatase-1 in spontaneously diabetic Chinese hamsters.

Hanley RM, Strada SJ, Steiner AL, Thompson WJ, Shenolikar S.

Mol Cell Endocrinol. 1987 Mar;50(1-2):115-22.

PMID:
3034694
41.
42.

Characterization of a Ca2+-calmodulin-stimulated cyclic GMP phosphodiesterase from bovine brain.

Shenolikar S, Thompson WJ, Strada SJ.

Biochemistry. 1985 Jan 29;24(3):672-8.

PMID:
2986683
43.

Adipocyte cyclic nucleotide phosphodiesterase activation by vanadate.

Souness JE, Thompson WJ, Strada SJ.

J Cyclic Nucleotide Protein Phosphor Res. 1985;10(4):383-96.

PMID:
2993388
44.

A new method for the analysis of cyclic AMP phosphodiesterase activity: evidence for two interconvertible forms.

Robison GA, Kishi Y, Kahl A, Skolnick MH, Smigel MD, Strada SJ, Thompson WJ.

Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;16:337-56. No abstract available.

PMID:
6326531
45.

Biochemical properties of high-affinity cyclic AMP phosphodiesterases.

Thompson WJ, Pratt ML, Strada SJ.

Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;16:137-48. No abstract available.

PMID:
6326519
46.

General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.

Strada SJ, Martin MW, Thompson WJ.

Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;16:13-29. No abstract available.

PMID:
6326518
47.

A kinetic analysis of the effects of inhibitor-1 and inhibitor-2 on the activity of protein phosphatase-1.

Foulkes JG, Strada SJ, Henderson PJ, Cohen P.

Eur J Biochem. 1983 May 2;132(2):309-13.

49.
50.

Catalytic and kinetic properties of purified high-affinity cyclic AMP phosphodiesterase from dog kidney.

Epstein PM, Strada SJ, Sarada K, Thompson WJ.

Arch Biochem Biophys. 1982 Oct 1;218(1):119-33. No abstract available.

PMID:
6293381

Supplemental Content

Loading ...
Support Center